Pulse 탐색 nav.journalClub 토론 트렌드 연구자

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

홈 탐색 nav.journalClub 트렌드

⌘+K

February 22, 2010

View Full Paper

Increased serum insulin-like growth factor 1 in early idiopathic Parkinson's disease

JGJana GodauKlinikum Kassel MHManon HerfurthGerman Center for Neurodegenerative Diseases BKBarbara KattnerUniversity of Tübingen

Key Points

Key points are not available for this paper at this time.

Abstract

Increased IGF-1 might be an interesting serum marker for early PD and potentially for subclinical dopaminergic dysfunction.

AI에게 질문

Like

Bookmark

Share

View Full Paper

AI에게 질문

Like

Bookmark

Share

View Full Paper

Increased serum insulin-like growth factor 1 in early idiopathic Parkinson's disease | Synapse

Cite This Study

Godau et al. (Mon,) studied this question.

synapsesocial.com/papers/69d76335086f9d6299f30ca1 https://doi.org/https://doi.org/10.1136/jnnp.2009.175752

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Comparison of pramipexole and amisulpride on alertness, autonomic and endocrine functions in healthy volunteers2006 · 37 citations
2Neuroendocrine and side effect profile of pramipexole, a new dopamine receptor agonist, in humans1992 · 41 citations
3Growth Hormone Therapy in the Glucocorticosteroid-Dependent Child: Metabolic and Linear Growth Effects2001 · 79 citations
4A Study of Dopaminergic Sensitivity in Parkinson's Disease: Comparison in “De Novo” and Levodopa-Treated Patients1996 · 13 citations
5Effect of hypoglycaemia, TRH and levodopa on plasma growth hormone, prolactin, thyrotropin and cortisol in Parkinson's disease before and during therapy1986 · 20 citations